New drug combo targets immune system in serious kidney disease

NCT ID NCT07038382

Summary

This study is testing a new drug, HLX79, given alongside an existing drug called rituximab, to see if it is safe and can help control active kidney disease caused by membranous nephropathy or lupus. It will involve about 24 adults who have not responded well to standard care. The main goal is to check for side effects, while also looking for early signs that the treatment reduces kidney damage.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS (LN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tsinghua Changgung Hospital

    NOT_YET_RECRUITING

    Beijing, China

  • Guangdong Provincial People's Hospital

    NOT_YET_RECRUITING

    Guangzhou, China

  • Jiangsu Province Hospital

    NOT_YET_RECRUITING

    Nanjing, China

  • Jiangxi Provincial People's Hospital

    NOT_YET_RECRUITING

    Nanchang, China

  • Peking University People's Hospital

    NOT_YET_RECRUITING

    Beijing, China

  • Renmin Hospital Of Wuhan University

    NOT_YET_RECRUITING

    Wuhan, China

  • Shanghai General Hospital

    RECRUITING

    Shanghai, China

  • Su Bei People's Hospital

    NOT_YET_RECRUITING

    Yangzhou, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, China

  • The First Affiliated Hospital Of Xiamen University

    NOT_YET_RECRUITING

    Xiamen, China

  • The First Affiliated Hospital Zhejiang University School Of Medicine

    NOT_YET_RECRUITING

    Hangzhou, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    NOT_YET_RECRUITING

    Luoyang, China

  • The First Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    NOT_YET_RECRUITING

    Xi'an, China

  • The Second Hospital of Anhui Medical University

    NOT_YET_RECRUITING

    Hefei, China

  • Xiangya Hospital Of Gentral South University

    NOT_YET_RECRUITING

    Changsha, China

  • Zhongdong Hospital Southeast University

    NOT_YET_RECRUITING

    Nanjing, China

Conditions

Explore the condition pages connected to this study.